$2.7 Billion is the total value of Nantahala Capital Management's 108 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 24.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IWM | Sell | ISHARES TRput | $408,619,000 | -9.0% | 2,700,000 | -6.5% | 15.14% | +9.5% |
| EXAS | Buy | EXACT SCIENCES CORPput | $124,186,000 | -18.8% | 1,374,200 | +6.0% | 4.60% | -2.3% |
| SGMS | SCIENTIFIC GAMES CORPcall | $121,906,000 | +2.7% | 5,990,400 | 0.0% | 4.52% | +23.6% | |
| QQQ | New | INVESCO QQQ TRput | $103,846,000 | – | 550,000 | +100.0% | 3.85% | – |
| CVNA | CARVANA COcall | $102,465,000 | +5.4% | 1,552,500 | 0.0% | 3.80% | +26.9% | |
| QURE | Buy | UNIQURE NV | $77,493,000 | -31.3% | 1,968,838 | +36.5% | 2.87% | -17.3% |
| QURE | Buy | UNIQURE NVcall | $77,342,000 | -37.2% | 1,965,000 | +24.6% | 2.87% | -24.5% |
| FCAU | FIAT CHRYSLER AUTOMOBILES Ncall | $75,369,000 | -6.3% | 5,820,000 | 0.0% | 2.79% | +12.8% | |
| CDXS | CODEXIS INC | $73,560,000 | -25.6% | 5,363,484 | 0.0% | 2.73% | -10.4% | |
| ARQL | Sell | ARQULE INC | $72,131,000 | -37.0% | 10,060,105 | -3.2% | 2.67% | -24.2% |
| THC | Buy | TENET HEALTHCARE CORPcall | $69,213,000 | +32.5% | 3,129,000 | +23.7% | 2.56% | +59.4% |
| XBI | Sell | SPDR SERIES TRUSTput | $68,625,000 | -29.9% | 900,000 | -19.4% | 2.54% | -15.7% |
| VAC | Sell | MARRIOTT VACTINS WORLDWID CO | $68,203,000 | +5.2% | 658,262 | -2.1% | 2.53% | +26.6% |
| RH | Sell | RH | $64,182,000 | -11.2% | 375,707 | -39.9% | 2.38% | +6.8% |
| CASH | META FINL GROUP INC | $58,689,000 | +16.3% | 1,799,727 | 0.0% | 2.18% | +39.9% | |
| QADA | Buy | QAD INCcl a | $57,758,000 | +18.1% | 1,250,722 | +2.8% | 2.14% | +42.1% |
| DXPE | Buy | DXP ENTERPRISES INC NEW | $55,636,000 | +2.7% | 1,602,433 | +12.1% | 2.06% | +23.6% |
| RH | Sell | RHcall | $53,811,000 | +29.5% | 315,000 | -12.4% | 1.99% | +55.8% |
| THC | Sell | TENET HEALTHCARE CORP | $44,282,000 | -13.3% | 2,001,914 | -19.0% | 1.64% | +4.3% |
| LXFR | LUXFER HOLDINGS PLC | $40,535,000 | -36.5% | 2,601,749 | 0.0% | 1.50% | -23.6% | |
| CZR | CAESARS ENTMT CORPcall | $38,839,000 | -1.4% | 3,331,000 | 0.0% | 1.44% | +18.7% | |
| HCA | HCA HEALTHCARE INCput | $38,534,000 | -10.9% | 320,000 | 0.0% | 1.43% | +7.2% | |
| WRLD | Sell | WORLD ACCEP CORP DEL | $34,651,000 | -65.8% | 271,753 | -56.0% | 1.28% | -58.8% |
| PRTY | Buy | PARTY CITY HOLDCO INC | $34,408,000 | +8.5% | 6,025,989 | +39.3% | 1.28% | +30.5% |
| W | Buy | WAYFAIR INCcl a | $33,958,000 | +28.5% | 302,870 | +67.4% | 1.26% | +54.5% |
| DLB | Buy | DOLBY LABORATORIES INC | $33,722,000 | +16.9% | 521,693 | +16.8% | 1.25% | +40.6% |
| GDEN | GOLDEN ENTMT INC | $32,557,000 | -5.1% | 2,449,713 | 0.0% | 1.21% | +14.2% | |
| IMXI | Sell | INTERNATIONAL MNY EXPRESS IN | $30,929,000 | -25.2% | 2,251,010 | -23.3% | 1.15% | -10.0% |
| SGMS | Buy | SCIENTIFIC GAMES CORP | $29,246,000 | +23.0% | 1,437,167 | +19.8% | 1.08% | +48.1% |
| TBBK | BANCORP INC DEL | $26,871,000 | +11.0% | 2,714,238 | 0.0% | 1.00% | +33.5% | |
| AKBA | AKEBIA THERAPEUTICS INC | $22,695,000 | -19.0% | 5,789,561 | 0.0% | 0.84% | -2.5% | |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $21,934,000 | +12.3% | 2,852,260 | 0.0% | 0.81% | +35.0% | |
| ONDK | Buy | ON DECK CAP INC | $21,452,000 | -18.1% | 6,384,602 | +1.1% | 0.80% | -1.5% |
| ENT | GLOBAL EAGLE ENTMT INC | $20,820,000 | +6.5% | 28,835,876 | 0.0% | 0.77% | +28.2% | |
| BDSI | Buy | BIODELIVERY SCIENCES INTL IN | $20,402,000 | -4.3% | 4,846,167 | +5.7% | 0.76% | +15.1% |
| CRHM | Buy | CRH MEDICAL CORP | $20,086,000 | +6.2% | 6,534,155 | +4.0% | 0.74% | +27.8% |
| DHX | Buy | DHI GROUP INC | $19,243,000 | +12.1% | 4,998,075 | +3.9% | 0.71% | +34.8% |
| HTZGQ | Buy | HERTZ GLOBAL HLDGS INCcall | $18,569,000 | +38.2% | 1,341,700 | +59.4% | 0.69% | +66.2% |
| AABA | ALTABA INC | $17,210,000 | -71.9% | 883,464 | 0.0% | 0.64% | -66.2% | |
| CURO | Sell | CURO GROUP HLDGS CORP | $16,326,000 | -9.4% | 1,229,332 | -24.6% | 0.60% | +9.0% |
| RDNT | RADNET INC | $16,224,000 | +4.1% | 1,129,814 | 0.0% | 0.60% | +25.2% | |
| ESTA | Buy | ESTABLISHMENT LABS HLDGS INC | $16,110,000 | -7.6% | 851,922 | +7.5% | 0.60% | +11.2% |
| JYNT | Sell | JOINT CORP | $15,798,000 | -2.0% | 848,881 | -4.2% | 0.58% | +17.9% |
| XELA | EXELA TECHNOLOGIES INC | $15,078,000 | -46.1% | 12,777,887 | 0.0% | 0.56% | -35.2% | |
| PAR | Buy | PAR TECHNOLOGY CORP | $14,928,000 | -11.8% | 628,017 | +4.6% | 0.55% | +6.1% |
| MED | New | MEDIFAST INC | $12,581,000 | – | 121,407 | +100.0% | 0.47% | – |
| CUE | CUE BIOPHARMA INC | $11,618,000 | -6.2% | 1,378,198 | 0.0% | 0.43% | +12.8% | |
| FALCON MINERALS CORP | $11,603,000 | -31.5% | 2,017,894 | 0.0% | 0.43% | -17.6% | ||
| AFI | Sell | ARMSTRONG FLOORING INC | $10,465,000 | -50.9% | 1,637,724 | -24.3% | 0.39% | -40.9% |
| HTZGQ | Buy | HERTZ GLOBAL HLDGS INC | $10,408,000 | +48.2% | 751,995 | +70.9% | 0.39% | +78.7% |
| VMD | New | VIEMED HEALTHCARE INC | $10,341,000 | – | 1,498,100 | +100.0% | 0.38% | – |
| RFL | RAFAEL HLDGS INC | $10,173,000 | -27.1% | 485,366 | 0.0% | 0.38% | -12.3% | |
| SRL | Sell | SCULLY ROYALTY LTD | $9,752,000 | -12.7% | 837,048 | -0.3% | 0.36% | +4.9% |
| AGS | New | PLAYAGS INC | $9,252,000 | – | 900,000 | +100.0% | 0.34% | – |
| SIGA | SIGA TECHNOLOGIES INC | $9,219,000 | -9.9% | 1,800,514 | 0.0% | 0.34% | +8.6% | |
| FTACU | FINTECH ACQUISITION CORP IIIunit 12/01/2023 | $9,000,000 | -0.3% | 842,730 | 0.0% | 0.33% | +20.1% | |
| Buy | APTOSE BIOSCIENCES INC | $8,898,000 | -0.1% | 4,267,530 | +25.1% | 0.33% | +20.4% | |
| SIC | SELECT INTERIOR CONCEPTS INCcl a | $8,475,000 | +11.3% | 653,461 | 0.0% | 0.31% | +34.2% | |
| AKBA | AKEBIA THERAPEUTICS INCcall | $7,840,000 | -19.0% | 2,000,000 | 0.0% | 0.29% | -2.3% | |
| CEMI | CHEMBIO DIAGNOSTICS INC | $7,589,000 | +0.5% | 1,239,983 | 0.0% | 0.28% | +20.6% | |
| SHOS | Sell | SEARS HOMETOWN & OUTLET STOR | $7,491,000 | +47.3% | 2,131,251 | -0.2% | 0.28% | +77.1% |
| IGT | INTERNATIONAL GAME TECHNOLOGcall | $7,105,000 | +9.6% | 500,000 | 0.0% | 0.26% | +31.5% | |
| NEOS | NEOS THERAPEUTICS INC | $6,823,000 | +14.7% | 4,610,000 | 0.0% | 0.25% | +38.3% | |
| ELVT | Sell | ELEVATE CREDIT INC | $6,603,000 | -6.5% | 1,568,411 | -8.5% | 0.24% | +12.4% |
| SSKN | STRATA SKIN SCIENCES INC | $6,130,000 | -13.6% | 2,851,001 | 0.0% | 0.23% | +3.7% | |
| APEN | APOLLO ENDOSURGERY INC | $5,957,000 | +1.2% | 1,810,562 | 0.0% | 0.22% | +22.1% | |
| PRTY | New | PARTY CITY HOLDCO INCcall | $5,710,000 | – | 1,000,000 | +100.0% | 0.21% | – |
| SNSS | Buy | SUNESIS PHARMACEUTICALS INC | $5,543,000 | +71.0% | 7,700,146 | +72.7% | 0.20% | +105.0% |
| CBIO | Buy | CATALYST BIOSCIENCES INC | $5,219,000 | -32.1% | 1,062,843 | +1.9% | 0.19% | -18.6% |
| INSUU | INSURANCE ACQUISITION CORPunit 03/31/2024 | $5,210,000 | +0.7% | 500,000 | 0.0% | 0.19% | +21.4% | |
| LINC | LINCOLN EDL SVCS CORP | $5,069,000 | -9.9% | 2,436,805 | 0.0% | 0.19% | +8.7% | |
| ARYAU | ARYA SCIENCES ACQUISITION COunit 10/04/2023 | $4,964,000 | +2.5% | 452,944 | 0.0% | 0.18% | +23.5% | |
| NATR | NATURES SUNSHINE PRODUCTS IN | $4,837,000 | -12.2% | 583,510 | 0.0% | 0.18% | +5.3% | |
| RMBL | RUMBLEON INCcl b | $4,723,000 | -35.5% | 1,634,350 | 0.0% | 0.18% | -22.2% | |
| GLMD | GALMED PHARMACEUTICALS LTD | $4,203,000 | -35.9% | 879,200 | 0.0% | 0.16% | -22.8% | |
| TA | New | TRAVELCENTERS OF AMERICA INC | $4,158,000 | – | 337,390 | +100.0% | 0.15% | – |
| EMMS | EMMIS COMMUNICATIONS CORP | $3,917,000 | +5.5% | 781,783 | 0.0% | 0.14% | +27.2% | |
| MACK | Buy | MERRIMACK PHARMACEUTICALS IN | $3,364,000 | -14.1% | 747,635 | +15.4% | 0.12% | +3.3% |
| DVD | DOVER MOTORSPORTS INC | $3,357,000 | -4.8% | 1,695,541 | 0.0% | 0.12% | +13.8% | |
| HTGM | New | HTG MOLECULAR DIAGNOSTICS IN | $3,323,000 | – | 5,000,000 | +100.0% | 0.12% | – |
| ACER | ACER THERAPEUTICS INC | $3,160,000 | -18.2% | 990,655 | 0.0% | 0.12% | -1.7% | |
| SCPL | SCIPLAY CORPcl a | $2,675,000 | -22.0% | 250,000 | 0.0% | 0.10% | -6.6% | |
| ZVO | Buy | ZOVIO INC | $2,135,000 | -39.8% | 1,083,906 | +9.5% | 0.08% | -27.5% |
| CCXI | New | CHEMOCENTRYX INCcall | $2,034,000 | – | 300,000 | +100.0% | 0.08% | – |
| STRM | STREAMLINE HEALTH SOLUTIONS | $1,909,000 | -28.2% | 1,760,297 | 0.0% | 0.07% | -13.4% | |
| DCPH | New | DECIPHERA PHARMACEUTICALS IN | $1,298,000 | – | 38,247 | +100.0% | 0.05% | – |
| DRIO | DARIOHEALTH CORP | $1,302,000 | -42.6% | 4,281,652 | 0.0% | 0.05% | -31.4% | |
| CVNA | Sell | CARVANA COcl a | $1,223,000 | -97.1% | 18,529 | -97.2% | 0.04% | -96.5% |
| CHAC | New | CHARDAN HEALTHCARE ACQUISITI | $1,197,000 | – | 100,000 | +100.0% | 0.04% | – |
| FALCON MINERALS CORP*w exp 07/21/202 | $942,000 | +12.9% | 878,022 | 0.0% | 0.04% | +34.6% | ||
| MOTS | MOTUS GI HLDGS INC | $827,000 | -34.7% | 417,708 | 0.0% | 0.03% | -20.5% | |
| FBIO | New | FORTRESS BIOTECH INC | $475,000 | – | 336,621 | +100.0% | 0.02% | – |
| RBCAA | Exit | REPUBLIC BANCORP KYcl a | $0 | – | -7,371 | -100.0% | -0.01% | – |
| HTZRT | Exit | HERTZ GLOBAL HLDGS INCright 07/12/2019 | $0 | – | -440,000 | -100.0% | -0.03% | – |
| CHACU | Exit | CHARDAN HEALTHCARE ACQUISITIunit 12/13/2023 | $0 | – | -100,000 | -100.0% | -0.03% | – |
| ASCMA | Exit | ASCENT CAP GROUP INC | $0 | – | -1,794,260 | -100.0% | -0.06% | – |
| VIVE | Exit | VIVEVE MED INC | $0 | – | -6,581,465 | -100.0% | -0.08% | – |
| GTTN | Exit | GTT COMMUNICATIONS INC | $0 | – | -235,486 | -100.0% | -0.13% | – |
| TA | Exit | TRAVELCENTERS AMER LLC | $0 | – | -1,666,365 | -100.0% | -0.19% | – |
| TLYS | Exit | TILLYS INCcl a | $0 | – | -858,103 | -100.0% | -0.20% | – |
| PIRS | Exit | PIERIS PHARMACEUTICALS INC | $0 | – | -1,477,563 | -100.0% | -0.21% | – |
| SPB | Exit | SPECTRUM BRANDS HLDGS INC NE | $0 | – | -417,912 | -100.0% | -0.69% | – |
| SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -300,000 | -100.0% | -2.71% | – |
| XLV | Exit | SELECT SECTOR SPDR TRput | $0 | – | -1,500,000 | -100.0% | -4.28% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-14
About Nantahala Capital Management
Nantahala Capital Management is a hedge fund that was founded in 2004 by Wil Harkey. The firm is headquartered in Connecticut and has additional offices in New York and North Carolina. Nantahala Capital Management primarily invests in the technology, healthcare, and consumer sectors. The firm has a long-term investment approach and seeks to identify undervalued companies with strong growth potential.
Wil Harkey serves as the CEO and Chief Investment Officer of Nantahala Capital Management. He has over 20 years of experience in the finance industry and previously worked at Goldman Sachs and Maverick Capital. In addition to Harkey, the firm's leadership team includes COO and General Counsel, David Kozak, and CFO, Michael Kozak.
Nantahala Capital Management has a strong track record of generating positive returns for its investors. The firm's flagship fund, the Nantahala Fund, has delivered an annualized return of over 20% since its inception in 2006. The firm's success can be attributed to its disciplined investment approach and focus on long-term value creation.
Overall, Nantahala Capital Management is a well-respected hedge fund with a talented leadership team and a strong track record of performance. However, as with any investment, it is important for investors to conduct their own due diligence and carefully consider the risks before investing in the firm's funds.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES TR | 42 | Q3 2023 | 27.2% |
| CODEXIS INC | 42 | Q3 2023 | 3.9% |
| PATHWARD FINANCIAL INC | 35 | Q3 2023 | 6.3% |
| SCIENTIFIC GAMES CORP | 34 | Q3 2022 | 5.3% |
| DOVER MOTORSPORTS INC | 34 | Q3 2021 | 0.5% |
| GOLDEN ENTMT INC | 33 | Q3 2023 | 2.1% |
| QAD INC | 32 | Q3 2021 | 2.6% |
| SCIENTIFIC GAMES CORP | 31 | Q4 2021 | 7.7% |
| DOLBY LABORATORIES INC | 31 | Q4 2020 | 5.6% |
| LINCOLN EDL SVCS CORP | 31 | Q4 2021 | 0.7% |
View Nantahala Capital Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AYTU BIOPHARMA, INC | June 16, 2023 | 1,086,812 | 19.7% |
| Acer Therapeutics Inc. | February 14, 2023 | 1,226,191 | 7.5% |
| Aeglea BioTherapeutics, Inc. | February 14, 2023 | 4,611,302 | 7.5% |
| AKUMIN INC. | February 14, 2023 | 2,206,960 | 2.5% |
| ALTA EQUIPMENT GROUP INC. | February 14, 2023 | 1,188,985 | 3.7% |
| Apollo Endosurgery, Inc. | February 14, 2023 | 4,056,627 | 9.9% |
| Autolus Therapeutics plc | February 14, 2023 | 7,782,018 | 4.7% |
| Bioventus Inc. | February 14, 2023 | 3,168,574 | 5.1% |
| CATALYST BIOSCIENCES, INC. | February 14, 2023 | 438,055 | 1.4% |
| Drive Shack Inc. | February 14, 2023 | 6,500,000 | 7.0% |
View Nantahala Capital Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-21 |
| 4 | 2024-03-15 |
| SC 13G | 2024-03-11 |
| 13F-HR/A | 2024-02-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Nantahala Capital Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.